In order for the stock price to hit the forecast high, the stock would need to surge -44.75% from its current level, while the stock would need to crash -61.33% from its current level to reach the projected low. Short term estimates and forecasts for Ocugen, Inc. (OCGN). Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and develop a vaccine to save lives from COVID-19. However, this figure declines on the past 10-day timeline to an average of 54.68 Million. The listed name for OCGN is Ocugen, Inc. Common Stock. Its pipeline includes OCU400, OCU410, OCU200, OCU200, and OCU300. Let’s Jump into the First Majestic Silver Corp. (NYSE:AG) Stock Forecast, Alcoa Corporation (NYSE:AA) Stock Forecast for 2021: Bullish Signs Point to $37 per Share. Kevin Freeman - March 1, 2021 0 The drugmaker Ocugen Inc (OCGN) has been surging nearly 4% at the start of the premarket session today. What’s Driving Ocugen (OCGN) Stock Higher Pre-Market Today? Nelly Dodson - November 20, 2020. Ocugen announced that it completed its public stock offering and raised an impressive $23 million in new capital that ... Ethereum price aims for a significant recovery … Is Cloudflare, Inc. (NYSE:NET) Stock an Instant Disaster or an Incredible Opportunity? More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing. The share float percentage for the stock currently stands at 13.57%. The company plans... Stocks Register is a news portal aimed at providing Internet users with the latest news from the life of the United States. Save my name, email, and website in this browser for the next time I comment. Such impressive past performance is great, but which of these Reddit stocks … The OCGN stock was last observed hovering at around $1.83 in the last trading session, with the day’s gains setting it 1.24% off its average median price target of $1.00 for the next 12 months. Taking into account the 52-week price action we note that the stock hit a 52-week high of $18.77 and 52-week low of $0.17. Click here now. Over the past 30 days, the shares of Ocugen, Inc. (NASDAQ:OCGN) have changed 487.73%. Market Globalist. Ocugen, Inc. has a market cap of $526.58 Million and is expected to release its quarterly earnings report on Mar 25, 2021- Mar 29, 2021. The company cannot disappoint investors with poor results in its clinical trials. Every day the website publishes the latest news of the business, technologies, politics, economy, culture, sports and the most interesting events in the world. If we look at the company’s 10-day average daily trading volume, we find that it stood at 78.28 Million shares traded. Get the hottest stocks to trade every day before the market opens 100% free. Ocugen Inc. stock is now -1.09% down from its year-to-date (YTD) trading value. Ocugen, Inc. (Nasdaq: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, today announced that it has entered into definitive agreements with healthcare-focused institutional investors for the sale of an aggregate of 3,000,000 shares of its common stock at a … Small Cap Stock Clovis Oncology, Inc. (CLVS) is a Hold – Analysts. Stocks rose, recovering some losses after last week’s selloff. Home; Top Movers; Financial Markets; Equities Score; Trending Stocks; Home Tags Ocugen stock. The other major institutional holder is Blackrock Inc., with the holding of over 2.23 Million shares as of December 30, 2020. Over the past six months meanwhile, it has gained 451.87% and gained 13.66% year-on date. The Ocugen stock could continue the rally today that it has started in last trading, or can at least raise the investor’s sentiment for a while in pre-market as well as regular session today. Current records show that the company has 188.03 Million in outstanding shares. OCGN disclosed a change of -15.58% and its listed share value at $7.75 in the recent trade transaction. The stats also highlight that short interest as of February 11, 2021, stood at 8.16 Million shares, which puts the short ratio at the time at 0.08. According to TipRanks.com, Nakae is a 4-star analyst with an average return of 7.1% and a 47.3% success rate. … Forgot your password? Join now to get the NewsHeater.com pre-market morning brief 100% free. I hate to let my emotions inform my trading, but I’m really rooting for a full recovery. It is understandable that investor optimism is growing ahead of the company’s current quarter results. Notably, we see that shares short in February fell slightly given the previous month’s figure stood at 14.8 Million. We do not sell or share your information with anyone. Read More The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. Why Ocugen Stock Rocketed 200% Today The biotech is raising the cash it needs to fund its experimental coronavirus vaccine's clinical development program. OCGN Stock saw the intraday high of $0.9577 and lowest of $0.6742 per share. Click here to get the full story… along with our long list of backdoor Bitcoin strategies. Recover your password. Welcome! Ocugen, Inc. (Nasdaq: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, announced that it has closed the previously announced registered direct offering for the sale of an aggregate of 3,000,000 shares of its common stock for gross proceeds of approximately … Ocugen Inc. stock has also loss -6.31% of its value over the past 7 days. Pinterest. However, its potential could be counted higher as its co-developed vaccine for vast market of India could bring in strong revenues at an accelerated pace. The new note on the price target was released on February 04, 2021, representing the official price target for Ocugen Inc. stock. The information agency "Marketing Sentinel" was established at the end of 2004. In that case, then, we find that the current price level is -49.4% off the targeted high while a plunge would see the stock lose -95.57% from current levels. However, its potential could be counted higher as its co-developed vaccine for vast market of India could bring in strong revenues at an accelerated pace. Recover your password. The company report on February 11, 2021 that Ocugen, Inc. IA "Marketing Sentinel" seeks to provide the news and analytical information to both American and foreign audiences, events and events in the USA and all over the world reliably, objectively and promptly. Additionally, there is a decline of -1380% for Gilead Sciences Inc (GILD) in last trading while the stock has seen an overall apprecation of 409.8% over the past year. Is ADT Inc. (NYSE:ADT) Dead in the Water? If we look at who the major shareholders are, we find that insiders hold 3.26% of Ocugen, Inc. shares while 13.12% of the shares are in the hands of institutional holders. Join now to get the Newsheater.com pre-market morning brief 100% free. Year-to-date, Ocugen, Inc. shares have moved 763.93%, while the 5-day performance has seen it change 773.48%. NASDAQ:OCGN has finally hit a speed bump as the penny biotech stock surged to a new all-time high in 2021, already returning over 500% to its … Find real-time OCGN - Ocugen Inc stock quotes, company profile, news and forecasts from CNN Business. By now, you’re likely wondering if Ocugen stock is a “Buy.” Of course, nobody can know for sure, but most certainly the new COVID-19 vaccine development leaves room for optimism where there was little before. Ocugen, Inc. OCGN will provide updates on its pipeline developments when it reports fourth-quarter 2020 results. Ocugen, (OCGN) traded 2342047 shares on hands in most recent trading session and observed an average volume with 84552.36K shares. In the press release, the company said that its co-development partner, Bharat Biotech, announced the results of the first interim analysis of the Phase 3 study of COVAXIN. Ocugen, Inc. (NASDAQ:OCGN) is shattering all records and is currently up over 200%. Ocugen, Inc., which has a market valuation of $1.67 Billion, is expected to release its quarterly earnings report Mar 25, 2021- Mar 29, 2021. Announces Closing of $23 Million Registered Direct Offering of Common Stock. We do not sell or share your information with anyone. Password recovery. From this we can glean that short interest is 4.34% of company’s current outstanding shares. The Verdict on Ocugen Stock. Get the hottest stocks to trade every day before the market opens 100% free. A new Morgan Stanley report identifies 40 "mispriced" stocks as a way to play the eventual reopening. Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. Click Here to get the full report on Ocugen Inc (OCGN) Stock. The expected earnings per share for the stock is -$0.02. If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +50.6% over the past 5 years. Ocugen (OCGN) stock ran up today. Short interest in the company has seen 14.8 Million shares shorted with days to cover at 0.26. None out of 4 have rated it as a Hold, with 4 advising it as a Buy. By. Here’s Why New Gold Inc. (NYSE:NGD) is an Attractive Pick for Investors Now. ... OMI stock began a recovery that accelerated last fall. Turning out attention to how the Ocugen, Inc. stock has performed in comparison to its peers in the industry, here’s what we find: OCGN’s stock is -0.93% on the day and +1774.86% in the past 12 months, while Bristol-Myers Squibb Company (BMY) traded +1.55% in the latest session and is positioned +0.23% up on its price 12 months ago. Ocugen (OCGN) is a latecomer to the coronavirus stock party. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. Is Beyond Meat, Inc. (NASDAQ:BYND) Potentially Life-Changing Stock? Even if you’re not actively in crypto, you deserve to know what’s actually going on... OCGN Stock: Why Red-Hot Ocugen Is on the Move Today Sarah Smith 2/25/2021. Ocugen, Inc. (NASDAQ:OCGN) has a beta value of 3.77 and has seen 719,521,503 shares traded in the last trading session. Volume today is 89,839,857 compared to average volume of 93,626,779. The shares of common stock described above are being offered pursuant to a “shelf” registration statement (File No. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the OCGN stock to lose ahead of the earnings release. The Ocugen stock could continue the rally today that it has started in last trading, or can at least raise the investor’s sentiment for a while in pre-market as well as regular session today. Ocugen Inc. (NASDAQ:OCGN) went down by -1.94% from its latest closing price compared to the recent 1-year high of $0.96. Ocugen, Inc. engages in the development and commercialization of therapies for eye diseases. Ocugen (OCGN) is a latecomer to the coronavirus stock party. OCGN stock news. Nevertheless, … The top two institutional holders are Vanguard Group, Inc. (The) with over 7.44 Million shares worth more than $2.31 Million. OCGN stock is a deeply flawed investment that only received the most miraculous of lifelines. your email. Ocugen stock soars after partner Bharat Biotech COVID-19 vaccine candidate shows 81% efficacy Mar. The stock added 165.54% on its value in the past month. Log into your account. OCGN Stock: Ocugen Flies on COVID-19 News March 3, 2021 by Joshua Rodriguez Ocugen Inc (NASDAQ: OCGN ) is up big in the market this morning, and for good reason. The OCGN stock was last observed hovering at around $0.29 in the last trading session, with the day’s gains setting it 0.52% off its average median price target of $1.00 for the next 12 months. Shares of Ocugen were up 35% on Wednesday morning. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. Ocugen’s flagship product, OCU300, is a needed source of encouragement for patients. The surge comes as the biopharmaceutical company announced the sale of 3 … On the technical perspective front, indicators give OCGN a short term outlook of 50% Buy on average. Where do analysts think the Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) is going, Will Vislink Technologies Inc. (VISL) be successful in remaining Competitive, Foresight Autonomous Holdings ADR (FRSX) Giving Back Gains Made on Successful Trial News, Moderna Inc. (MRNA) Is All Set To Increase COVID-19 Vaccine Production. The indicator jumps to 29.49% when calculated based on the past 30 days. 100% Free, Get The Best Stocks To Trade Every Day!...100% Free. Earnings growth for 2021 is a modest +89.6%. The stock has traded between $2.01 and $3.73 so far today. But in true latecomer fashion, it has made a dazzling entrance. 7 Blue-Chip Stocks With Gains and Pedigree The market cap for OCGN stock reached $347.88 million, with 162.03 million shares outstanding and 155.85 million shares in the current float. As we've seen from the small biotech stock in recent weeks, Ocugen's fortunes are now almost entirely tied … Ocugen, Inc. Ocugen's stock has skyrocketed 3,071.5% over the past three months, while the iShares Nasdaq Biotechnology ETF undefined has tacked on 6.8% … Is Globalstar, Inc. (NYSE:GSAT) Dead in the Water? your email. Analysts think Ocugen, Inc. (NASDAQ:OCGN) could rise 75.44% from current levels. In last trading session, Ocugen, Inc. (NASDAQ:OCGN) saw 25,190,577 shares changing hands with its beta currently measuring 2.5. Ocugen stock soars after partner Bharat Biotech COVID-19 vaccine candidate shows 81% efficacy Mar. In general, analysts have rated the stock Overweight, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares. Do You Have To Buy Fulgent Genetics Inc. (FLGT) Now Since It is On... MBIA, Inc. (MBI) Stock: Giving surprises in the market, BigCommerce Holdings Inc. (BIGC) To Team Up With Walmart Inc (WMT). Chardan Capital analyst Keay Nakae reiterated a Buy rating on Ocugen (OCGN – Research Report) yesterday and set a price target of $2.00.The company’s shares closed last Friday at $0.30, close to its 52-week low of $0.24. The overview shows that OCGN’s price is at present -16.03% off the SMA20 and 54.66% from the SMA50. Also, Gilead Sciences Inc (GILD) is currently showing downtrend of -0.93% while its price kept floating at 1774.86% over the past year. Ocugen, Inc., which has a market valuation of $364.61 Million, is expected to release its quarterly earnings report Mar 25, 2021- Mar 29, 2021. It’s free. Could 21Vianet Group, Inc. (NASDAQ:VNET) Post Life-Changing Returns? Sign in. Wall Street analysts have a consensus price target for the stock at $4.3, which means that the shares’ value could jump -72.8% from current levels. Elsewhere in the market, the S&P 500 Index has rallied 1.84% in today’s early trading, with the Dow Jones Industrial also seeing a positive session so far with +0.81%. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Buy, while an average of long term indicators are currently assigning the stock as 100% Buy. The stock price dropped -8.81%... MBIA, Inc. (MBI) that is currently ranked as a moderate buy by different brokers showed some positive growth in their last 3 months. Ocugen, Inc. (NASDAQ:OCGN)’s Major holders. Ocugen Inc. (NASDAQ: OCGN) is 67.76% higher on its value in year-to-date trading and has touched a low of $0.17 and a high of $3.05 in the current 52-week trading range. In order for the stock price to hit the forecast high, the stock would need to surge +41.61% from its current level, while the stock would need to crash -56.43% from its current level to reach the projected low. Click here now. Investors will no doubt be excited to see the share price rise to $12.5, which is the median consensus price, and at that level OCGN would be +46.2% from recent price. Another comparison is with Amgen Inc (AMGN) whose stock price is up 1.1% in the current trading session, and has flourished +8.15% over the past year. As of September 29, 2020, Vanguard Group, Inc. (The) held 4.59% of shares outstanding. Wall Street is all drooling over Ocugen’s recent deal with India-based vaccine … Ocugen, Inc. (NASDAQ:OCGN) price is hovering lower on Tuesday, Mar 09, sinking -0.93% below its previous close. Its founder and leader is Lewis Roberts. Chardan Capital Markets have made an estimate for Ocugen Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on February 09, 2021. The consensus among analysts is that Ocugen, Inc. (OCGN) is a Buy stock at the moment, with a recommendation rating of 2. Fulgent Genetics Inc. (FLGT) has increased the value of its share price by 413.00% over the past 12 months. The OCGN stock was last observed hovering at around $1.83 in the last trading session, with the day’s gains setting it 1.24% off its average median price target of $1.00 for the next 12 months. The stock, however, is off 6.88% from where it was a year ago. Ocugen, Inc. (OCGN) projections and forecasts Sporting 201.14% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Monday, Feb 08 when the OCGN stock price touched $18.77- or saw a rise of 15.77%. Ocugen (OCGN) stock more than tripled on Monday after reports that it sold shares to institutional investors at a massive premium. The stock’s 5-day price performance is 78.57%, … Besides... BigCommerce Holdings Inc. (NASDAQ: BIGC) announced that it would join forces with Walmart Inc (NYSE: WMT), one of the largest American retailers. Search. Click here to get the full story… along with our long list of backdoor Bitcoin strategies. New Vaccine Stock Ocugen Rides Santa Claus Rally December 24, 2020 December 29, 2020 Michael Spencer Vaccine stocks, EV stocks, E-commerce stocks, 2020 sure saw its share of wild stock stories. Recover your password. The OCGN stock price is -18.72% off its 52-week high price of $18.77 and 98.92% above the 52-week low of $0.17. How is the BSQUARE Corporation (NASDAQ:BSQR) performance outlook for the coming months? Earlier today, Ocugen Inc. announced $23 Million Registered Direct Offering of Common Stock Priced at a Premium to Market. Looking ahead, Ocugen may potentially recover, if … Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Ocugen Inc (OCGN) stock is trading at $3.09 as of 10:31 AM on Tuesday, Feb 2, a gain of $1.28, or 70.72% from the previous closing price of $1.81. The company’s 5Y monthly beta was ticking 4.52 while its P/E ratio in the trailing 12-month period read 0. Facebook. What is going on with this stock? Investors are also buoyed by the number of investors in a company, with Ocugen, Inc. having a total of 19 institutions that hold shares in the company. Ocugen, Inc. (NASDAQ:OCGN) has a beta value of 3.77 and has seen 719,521,503 shares traded in the last trading session. Insiders own 3.26% of the company shares, while shares held by institutions stand at 13.12% with a share float percentage of 13.57%. ET by Tomi Kilgore Ocugen stock soars 34% after announcing COVID-19 … More than 368M shares have exchanged hands with stock prices climbing as high as 15.90$. Should Value Hunters Buy HUYA Inc. (NYSE:HUYA) Stock? Share this article: Related Companies. It’s free. The ability... Marketing Sentinel is a free online newspaper packed with exclusive content, news, articles and much more! Search. Ocugen Inc (NASDAQ: OCGN) shares traded 74.1% higher at $9.14 at press time in the pre-market session on Monday.. Ocugen, Inc.(NASDAQ:OCGN): Although shares of Ocugen (OCGN) have rallied over the past month in response to the company’s announcement of plans to co-develop a COVID-19 vaccine candidate with India’s Bharat Biotech, the vaccine’s commercialization prospects look bleak. However, and it’s really important to emphasize this, the fundamentals will matter. OCGN Stock saw the intraday high of $1.85 and lowest of $1.72 per share. The 2021 Backdoor Crypto Portfolio (free). The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. Press Release reported on 12/10/20 that Ocugen Inc. Join now to get the NewsHeater.com pre-market morning brief 100% free. Considering analysts have assigned the stock a price target range of $10-$15 as the low and high respectively, we find the trailing 12-month average consensus price target to be $12.5. Ocugen intends to use the net proceeds from the offering for general corporate purposes, capital expenditures, working capital and general and administrative expenses. Based on this estimate, we see that today’s price at last check is roughly 16.96% off the estimated low and 75.44% off the forecast high. Foresight Autonomous company... A recent announcement from Moderna Inc. (MRNA) shows it will further increase its global vaccine production capacity of the Covid-19 vaccine. A Backdoor Way To Profit From Today’s Crypto Bull Market. The company’s 52-week high price is 17.40, which means current price is +323.53% above from all time high which was touched on 07/28/20. It also develops and sells microwave communications machinery utilizing coded orthogonal frequency... FSRX recently turned 9% lower as profit-takers stepped in after the stock made big gains this week on successful trial results. A password will be e-mailed to you. Additionally, there is a gain of 194% for Gilead Sciences Inc (GILD) in recent trading while the stock has seen an overall apprecation of 1818.93% over the past year. Ocugen stock forecast, price & news. Ocugen (OCGN) Attempts To Recover on Value Buying January 14, 2021 Jack Dawkins One of the stocks to have been in focus among investors in recent weeks is that of Ocugen Inc (NASDAQ: OCGN). As a result of the merger, after taking into account the reverse stock split, stockholders of Ocugen prior to the merger received shares of common stock of … Join now to get the Newsheater.com pre-market morning brief 100% free. It is understandable that investor optimism is growing ahead of the company’s current quarter results. The company, currently valued at $2.56 Billion, closed the last trade at $15.81 per share which meant it gained $10.56 on the day or 201.14% during that session. As of September 29, 2020, the former fund manager holds about 4.38% shares in the company for having 7094500 shares of worth $2.2 Million while later fund manager owns 416.23 Thousand shares of worth $132.9 Thousand as of November 29, 2020, which makes it owner of about 0.26% of company’s outstanding stock. The stock spiked 12.87% in intraday trading to $3.73- this Tuesday, Feb 02, hitting a weekly high. Announces Closing of $23 Million Registered Direct Offering of Common Stock Email Print Friendly Share February 10, 2021 21:00 ET | Source: Ocugen 3, 2021 at 8:20 a.m. The company has a negative earnings surprise … It is understandable that investor optimism is growing ahead of the company’s current quarter results. your email. In this case, analysts estimate an annual EPS growth of -0.74% for the year and -2% for the next year. Ocugen, Inc. (OCGN) projections and forecasts OCGN has now gained over 6,000 percent since December. You have entered an incorrect email address! WhatsApp. A look at today’s price movement shows that the recent level at last check reads $8.63, with intraday deals fluctuating between $8.20 and $8.85. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing. The stock, however, is off 6.05% from where it was a year ago. Get The Best Stocks To Trade Every Day!...100% Free, Get Best Morning Financial Newsletter... 100% Free. The share float percentage for the stock currently stands at 13.57%. China banks to see profit growth recovery in 2021: Stock analysis for ocugen inc (ocgn:nasdaq cm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Ocugen Inc (Ocugen Inc ) is higher by Thursday morning, with the stock climbing 15.30% in pre-market trading to 3.24. None of the analysts rate the stock as a Sell, while none rate it as Overweight. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 51.89, with weekly volatility standing at 21.27%. Ocugen Inc. (NASDAQ: OCGN) is 67.76% higher on its value in year-to-date trading and has touched a low of $0.17 and a high of $3.05 in the current 52-week trading range. Analyst projections state that OCGN is forecast to be at a low of $0.7 and a high of $1. Get help. … Ocugen (OCGN) Attempts To Recover on Value Buying January 14, 2021 Jack Dawkins One of the stocks to have been in focus among investors in recent weeks is that of Ocugen Inc (NASDAQ: OCGN). Ocugen is a high-risk play whose cash levels are dwindling. However, OCGN stock has inclined by 550.00% in the 3 months of the year. Vislink Technologies, Inc. ‎(VISL) ‎specializes in designing and manufacturing wireless communications solutions. The firm’s total holdings are worth over $4.07 Million and represent 1.37% of shares outstanding. 3, 2021 at 8:20 a.m. The company’s stock price has collected -3.74% of loss in the last five trading sessions. Ocugen Inc. (NASDAQ: OCGN) is 54.85% higher on its value in year-to-date trading and has touched a low of $0.17 and a high of $0.96 in the current 52-week trading range. None have rated the stock as Underweight. Even if you’re not actively in crypto, you deserve to know what’s actually going on... The PE ratio stands at 0 for Ocugen, Inc., compared to 0 for Bristol-Myers Squibb Company, and 19.12 for Amgen Inc. Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, announced it has determined to withdraw from stockholder consideration Item 2 set forth in its Definitive Proxy Statement filed with the Securities and Exchange Commission on October … The projected low price target is $0.7 while the price target rests at a high of $8. Ocugen, Inc. (OCGN) registered a 15.66% upside in the last session and has traded in the green over the past 5 sessions. Could EnLink Midstream, LLC (NYSE:ENLC) Post Life-Changing Returns? Save my name, email, and website in this browser for the next time I comment. An analysis of the Ocugen, Inc. (NASDAQ:OCGN) stock in terms of its daily trading volume indicates that the 3-month average is 90.59 Million. None analyst(s) have tagged the Ocugen, Inc. (OCGN) stock as Underperform, with none recommending Sell. Specifically, 4 analysts have assigned OCGN a recommendation rating as follows: 1 rate it as a Hold; 3 advise Buy while none analyst(s) assign an Outperform rating. Moderna, Supernus, Ocugen: What to Watch When the Stock Market Opens Today U.S. stock futures were higher as investors weighed a full slate of economic data Announces Plan to Postpone Annual Meeting of Stockholders. The PE ratio stands at 0 for Ocugen, Inc., compared to 0 for Bristol-Myers Squibb Company, and 18.48 for Amgen Inc. Twitter. Ocugen, Inc. (NASDAQ:OCGN)’s beta value is holding at 4.52, while the average true range (ATR) indicator is currently reading 2.17. The company’s 52-week high price is 3.50, which means current price is +29.29% above from all time high which was touched on 01/04/21. As for Ocugen, Inc., the P/E ratio stands at 0 lower than that of Bristol-Myers Squibb Company’s at 0 and Amgen Inc’s 18.5. Ocugen Inc. stock is now 38.46% up from its year-to-date (YTD) trading value. If we look at who the major shareholders are, we find that insiders hold 3.26% of Ocugen, Inc. shares while 13.12% of the shares are in the hands of institutional holders. Ocugen, Inc., formerly Histogenics Corporation is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of therapies for eye diseases. The stock acknowledged active focus on shares in the current trading session. your password. But the +371.58% upside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher. Friday, November 20, 2020 Sign in / Join ... Ocugen, Inc. (NASDAQ:OCGN) 1.57% up over a week, Can The Stock Hit well above $0.3244? Analyst projections state that OCGN is forecast to be at a low of $4 and a high of $13. If we dive deeper into the stock’s performance we see the positive picture represented by the PEG ratio, currently standing at 0. Ocugen, Inc. (NASDAQ:OCGN)’s Major holders. OCGN's short-term technical score of 94 indicates that the stock has traded more bullishly over the last month than 94% of stocks on the market. Ocugen stock is up nearly 380% year to date, while Zomedica's shares have soared more than 670%.